ANTIPSYCHOTIC AGENTS AND LITHIUM Flashcards
caused by a relative excess of dopamine in the mesolimbic-mesocortical pathway
Schizophrenia
Positivr symptoms
HIDES Hallucination Illusion Delusion Excitement Suspciousness
Negative Signs
Anhedonia
Avolition
Anergia
D1 receptor family?
D2 receptor family?
D1 fam - D1, 4, 5
D2 fam - D2, 3
addresses more of the positive symptoms
TYPICAL ANTIPSYCHOTICS
addresses both positive and negative symptoms
ATYPICAL ANTIPSYCHOTICS
higher chances of causing EPS
high potency typical antipsychotics
- haloperidol, droperidol
more likely to cause sedatiom and postural hypotension due to alpha receptor blockade
Low Potency Typical Antipsychotics
- thioridazine, chlorpromazine
with higher propensity to cause metabolic derangements (weight gain, endocrine problems)
Atypical antipsychotics
Blocks more D2 receptors than 5HT2A
Typical Antipsychotics
Atypical - blocks more 5HT2A receptors
TYPICAL ANTIPSYCHOTICS
PHENOTHIAZINES
PIPERIDINES
BUTYROPHENONE
PHENOTHIAZINES
Chlorpromazine
Levomepromazine
Prochlorperazine
Promethazine
Thiothexene
Flupentixol
Thioridazine
Fluphenazine
Perphenazine
Trifluoperazine
AE: RETINAL DEPOSITS
thioridazine
Phenothiazine with the most muscarinic blockade therefore has the least EPS amongst typical antipsychotics
Thioridazine
phenothiazine with quinidine like actions (prolongation of QT interval)
Thioridazine
Phenothiazine with significant Parkinson-like effect
Fluphenazine and Trifluoroperazine
BUTYROPHENONE
Haloperidol
Droperidol
USE: BUTYROPHENONE
Schizophrenia
BPD - manic phase
Huntington’s Disease
Tourette’s Syndrome
major tranquilizer with highest potential for EPS and neuroleptic malignant syndrome
Haloperidol
least sedating among typical antipsychotics
Haloperidol
ATYPICAL ANTIPSYCHOTICS
DIBENZODIAZEPINE THIENOBENZODIAZEPINE DIBENZOTHIAZEPINE BENZISOXAZOLE DIHYDROINDOLONE DIHYDROCARBOSTYRIL